Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People of any sex who have high blood pressure and are older than 75 years of age
- People with high blood pressure who are between 65 and 75 years old and also have at least one of the following conditions:
- Obesity
- Type 2 diabetes
- Obstructive sleep apnea (breathing interruptions during sleep)
- An ECG (heart tracing test) showing that the heart's left pumping chamber has become thickened or enlarged
- An ultrasound of the heart showing that the left pumping chamber has become thickened or enlarged
- An enlarged left upper chamber of the heart, detected by heart tests
- Coronary artery disease (narrowing or blockage of the heart's main blood vessels)
- Chronic kidney disease
- A type of heart failure where the heart still pumps at a reasonable rate (confirm with trial site)
- Regular alcohol intake
- Frequent irregular heartbeats originating in the upper chambers of the heart
Who may not be able to join:
- People who have ever had atrial fibrillation (a type of irregular heartbeat) of any kind
- People currently taking medications that may affect heart rhythm
- People with a history of serious, potentially dangerous irregular heartbeats originating in the lower chambers of the heart
- People with an underactive or overactive thyroid that is not well controlled
- People with significant chronic obstructive pulmonary disease (a serious long-term lung condition)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Daniel L Piskorz, MD, British Sanatorium Cardiovascular Research Center
Phone: 5493415416828
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
new atrial fibrillation; The absolute numbers of patients with new atrial fibrillation; The percentage of patients with new atrial fibrillation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.